Clinical Trials Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. May 7, 2019; 25(17): 2110-2121
Published online May 7, 2019. doi: 10.3748/wjg.v25.i17.2110
Table 1 Clinical characteristics of patients in the probiotics and placebo groups at baseline
CharacteristicProbiotics group (n = 66)Placebo group (n = 64)P-value
Age (yr)41.76 ± 9.3841.89 ± 9.750.937
Male n (%)39 (59.1)40 (62.5)0.691
BMI (kg/m2)24.61 ± 3.5123.90 ± 3.140.230
Smoking n (%)12 (18.2)10 (15.6)0.698
Waist circumference (cm)78.68 ± 5.0378.84 ± 6.490.874
RDQ score19.41 ± 4.2318.44 ± 5.170.244
GSRS scoreAbdominal pain6.38 ± 2.646.48 ± 3.200.846
Reflux10.35 ± 2.4810.31 ± 2.680.937
Diarrhea6.44 ± 1.976.89 ± 2.390.242
Indigestion7.53 ± 2.677.03 ± 2.170.245
Constipation5.48 ± 1.285.34 ± 2.130.647
Esophagitis grade at baseline (n)A26290.495
B22210.950
C13110.712
D530.493